参考文献のリスト
|
1) Heacache Classification Subcommittee of the International Headache Society.
The International Clasification of Headache Disorgers 2 nd edition. Cephalalgia
2004; 24 Suppl.1:1-160
2) 国際頭痛学会・頭痛分類委員会 . 国際頭痛分類第 2 版 (ICHD-II).
日本頭痛学会雑誌 2004;31:13-188.
3) MacGregor EA, Chia H, Vohrah RC, Wilkinson M. Migraine and menstruation:
a pilot study. Cephalalgia. 1990;10:305-10.
4) Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T. Efficacy and
tolerability of oral zolmitriptan in menstrually associated migraine: a randomized,
prospective, parallel-group, double-blind, placebo-controlled study. Headache.
2004;44:120-30.
5) Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, McCarroll KA, Lines
CR. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol.
200096:237-42
6) Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M. Pain-free
efficacy after treatment with sumatriptan in the mild pain phase of menstrually
associated migraine.Obstet Gynecol. 2003 Oct;102(4):835-42.
7) Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, Watson
C, Jobsis M, Batenhorst A, O'Quinn S. Naratriptan as short-term prophylaxis of
menstrually associated migraine: a randomized, double-blind, placebo-controlled
study. Headache. 2001;41:248-56.
8) Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen
sodium in menstrual migraine prophylaxis: a double-blind placebo controlled stud
y. Headache. 1990;30:705-9
9)
Al-Waili NS . Treatment of menstrual migraine with prostaglandin synthesis
inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res. 2000
19;5:176-82.
10) Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S, Liu J, Ramadan N,
Rebar R. Medical oophorectomy with and without estrogen add-back therapy in
the prevention of migraine headache. Headache. 2003;43:309-21.
|